Regeneron Pharmaceuticals (REGN) Cash & Equivalents (2009 - 2026)
Regeneron Pharmaceuticals (REGN) reported Cash & Equivalents of $3.66 billion for Q3 2026, up 46.0% from $2.51 billion a year earlier and up 49.0% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals posted Cash & Equivalents of $3.12 billion, up 25.3% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $2.49 billion in FY2024 (-8.9%), $2.73 billion in FY2023 (-12.1%), $3.11 billion in FY2022 (+7.6%) and $2.89 billion in FY2021 (+31.5%).
- The Q3 2026 figure ranks as the highest quarterly Cash & Equivalents since Q1 2023.
- Year over year, Cash & Equivalents gained in six of the last eight quarters, with growth averaging 16.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 132.7%); the low point was Q2 2023 (a decline of 42.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.46 billion (Q2 2026), $2.96 billion (Q1 2026) and $3.12 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.35 Bn | 1,259.96 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 655.58 Bn | 575.44 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 509.44 Bn | 477.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.14 Bn | 325.14 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 309.04 Bn | 282.62 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.57 Bn | 263.55 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 248.97 Bn | 200.62 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.95 Bn | 182.98 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 170.25 Bn | 117.91 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Regeneron Pharmaceuticals | 91.82 Bn | 57.17 Bn | 4.54 Bn | 3.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.66 Bn |
| Jun 30, 2026 | 2.46 Bn |
| Mar 31, 2026 | 2.96 Bn |
| Dec 31, 2025 | 3.12 Bn |
| Sep 30, 2025 | 2.51 Bn |
| Jun 30, 2025 | 2.00 Bn |
| Mar 31, 2025 | 3.09 Bn |
| Dec 31, 2024 | 2.49 Bn |
| Sep 30, 2024 | 2.01 Bn |
| Jun 30, 2024 | 1.92 Bn |
| Mar 31, 2024 | 2.60 Bn |
| Dec 31, 2023 | 2.73 Bn |
| Sep 30, 2023 | 2.15 Bn |
| Jun 30, 2023 | 1.94 Bn |
| Mar 31, 2023 | 3.92 Bn |
| Dec 31, 2022 | 3.11 Bn |
| Sep 30, 2022 | 3.49 Bn |
| Jun 30, 2022 | 3.40 Bn |
| Mar 31, 2022 | 3.35 Bn |
| Dec 31, 2021 | 2.89 Bn |
API Access
Regeneron Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();